肝SENP2通过SUMO化调控肝-脂肪组织交互控制全身代谢
该研究在脂肪肝中发现SENP2表达显著升高,利用肝特异性SENP2敲除小鼠证明其缺失可抵抗高脂饮食诱导的肝脂肪变和肥胖,机制上SENP2通过去SUMO化PPARα促进其泛素化降解,抑制FGF21表达和脂肪酸氧化。
要点
- 肝SENP2缺失可抵抗高脂饮食诱导的肝脂肪变和肥胖
- SENP2通过去SUMO化PPARα促其降解,抑制FGF21和脂肪酸氧化
- FGF21是SENP2缺失改善代谢的关键肝因子
核心结论
- 肝SENP2通过调控PPARα-FGF21轴和肝-脂肪组织交互来维持代谢平衡。
研究设计与样本
- 研究采用肝特异性SENP2敲除小鼠,并结合RNA测序和分子机制实验。
主要发现
- SENP2是脂肪肝中升高最显著的SENP,且受进食/禁食状态调节。
- Senp2-LKO小鼠抵抗高脂饮食诱导的肝脂肪变和肥胖。
- Senp2缺失上调肝脏脂肪酸氧化基因、下调脂肪生成基因,并激活脂肪组织产热。
- FGF21在Senp2-LKO小鼠中显著升高,缺失FGF21可逆转SENP2缺失的代谢益处。
- SENP2与PPARα互作并去SUMO化,促进其泛素化降解,抑制FGF21表达和脂肪酸氧化。
临床怎么用
- 肝SENP2-PPARα-FGF21轴可能为NAFLD和代谢紊乱提供潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NAFLD, characterized by aberrant triglyceride accumulation in liver, affects the metabolic remodeling of hepatic and nonhepatic tissues by secreting altered hepatokines. Small ubiquitin-related modifier (SUMO)-specific protease 2 (SENP2) is responsible for de-SUMOylation of target protein, with broad effects on cell growth, signal transduction, and developmental processes. However, the role of SENP2 in hepatic metabolism remains unclear. APPROACH AND RESULTS: We found that SENP2 was the most dramatically increased SENP in the fatty liver and that its level was modulated by fed/fasted conditions. To define the role of hepatic SENP2 in metabolic regulation, we generated liver-specific SENP2 knockout (Senp2-LKO) mice. Senp2-LKO mice exhibited resistance to high-fat diet-induced hepatic steatosis and obesity. RNA-sequencing analysis showed that Senp2 deficiency up-regulated genes involved in fatty acid oxidation and down-regulated genes in lipogenesis in the liver. Additionally, ablation of hepatic SENP2 activated thermogenesis of adipose tissues. Improved energy homeostasis of both the liver and adipose tissues by SENP2 disruption prompted us to detect the hepatokines, with FGF21 identified as a key factor markedly elevated in Senp2-LKO mice that maintained metabolic homeostasis. Loss of FGF21 obviously reversed the positive effects of SENP2 deficiency on metabolism. Mechanistically, by screening transcriptional factors of FGF21, peroxisome proliferator-activated receptor alpha (PPARα) was defined as the mediator for SENP2 and FGF21. SENP2 interacted with PPARα and deSUMOylated it, thereby promoting ubiquitylation and subsequent degradation of PPARα, which in turn inhibited FGF21 expression and fatty acid oxidation. Consistently, SENP2 overexpression in liver facilitated development of metabolic disorders. CONCLUSIONS: Our finding demonstrated a key role of hepatic SENP2 in governing metabolic balance by regulating liver-adipose tissue crosstalk, linking the SUMOylation process to metabolic regulation.
引用
- Liu Y, Dou X, Zhou WY, et al. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk. Hepatology. 2021. PMID: 33934381. doi:10.1002/hep.31881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。